Literature DB >> 1540487

The human platelet fibrinogen receptor: clinical and therapeutic significance.

M Cahill1, R Mistry, D B Barnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1540487      PMCID： PMC1381192          DOI： 10.1111/j.1365-2125.1992.tb03993.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  44 in total

Review 1.  Platelet adhesion.

Authors:  P G de Groot; J J Sixma
Journal:  Br J Haematol       Date:  1990-07       Impact factor: 6.998

2.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.

Authors:  C Gachet; J P Cazenave; P Ohlmann; C Bouloux; G Defreyn; F Driot; J P Maffrand
Journal:  Biochem Pharmacol       Date:  1990-12-15       Impact factor: 5.858

4.  Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study.

Authors:  L Janzon; D Bergqvist; J Boberg; M Boberg; I Eriksson; F Lindgärde; G Persson; B Almgren; B Fagher; T Kjellström
Journal:  J Intern Med       Date:  1990-05       Impact factor: 8.989

5.  Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

Authors:  E F Plow; G Marguerie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation.

Authors:  T Yasuda; H K Gold; R C Leinbach; H Yaoita; J T Fallon; L Guerrero; M A Napier; S Bunting; D Collen
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

7.  Correlation between fibrinogen binding to human platelets and platelet aggregability.

Authors:  E I Peerschke; M B Zucker; R A Grant; J J Egan; M M Johnson
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

8.  Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.

Authors:  J S Bennett; J A Hoxie; S F Leitman; G Vilaire; D B Cines
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair.

Authors:  G Di Minno; A M Capitanio; P Thiagarajan; J Martinez; S Murphy
Journal:  Blood       Date:  1983-06       Impact factor: 22.113

10.  125I-fibrinogen binding to platelets in myeloproliferative disease.

Authors:  R Mistry; M Cahill; C Chapman; J K Wood; D B Barnett
Journal:  Thromb Haemost       Date:  1991-09-02       Impact factor: 5.249
View more
  3 in total

Review 1.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

2.  Inflammation and Progression of CKD: The CRIC Study.

Authors:  Richard L Amdur; Harold I Feldman; Jayanta Gupta; Wei Yang; Peter Kanetsky; Michael Shlipak; Mahboob Rahman; James P Lash; Raymond R Townsend; Akinlolu Ojo; Akshay Roy-Chaudhury; Alan S Go; Marshall Joffe; Jiang He; Vaidyanathapuram S Balakrishnan; Paul L Kimmel; John W Kusek; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

3.  Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes.

Authors:  Jae-Seung Yun; Yong-Moon Park; Kyungdo Han; Hyung-Wook Kim; Seon-Ah Cha; Yu-Bae Ahn; Seung-Hyun Ko
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.